23
Views
0
CrossRef citations to date
0
Altmetric
Original Article

Overview: Recent Developments in Anthelmintic and Antiprotozoan Agents

Pages 197-208 | Published online: 03 Mar 2008

References

  • KATZ M, DESPOMMIER DD, GWADZ R: Par-asitic Diseases (1982). Springer-Verlag, New York.
  • An excellent review of disease and treatment.
  • KREIER JP, BAKER JR: Parasitic Protozoa (1987). Allen & Unwin Inc, Boston.
  • Ivermectin and Abamectin (1989) Campbell WC (Ed), Springer-Verlag, New York.
  • A definitive work on the action and applications of aver-mectins.
  • ROSENBLATT JE: Antiparasitic Agents. Mayo Clin. Proc. (1992) 67:276–287.
  • Update on the problems of resistance and chemotherapy of parasitic diseases.
  • MEHTA K, CHANDRASHEKAR R, RAO UR: Re-cent Developments in Antifilarial Agents. Curr. Opin. Thera. Patents (1992) 2(5):641–654.
  • CAMPBELL WC: Ivermectin as an Antipara-sitic Agent for Use in Humans. Ann. Rev. Mi-crobiol. (1991) 45:445–74.
  • CLARK JN, DAURIO CP, PLUE RE, WALLACE DH, LONGHOFER SL: Efficacy of ivermectin and pyrantel pamoate combined in a chew-able formulation against heartworm, hook-worm, and ascarid infections in dogs. Am. .1. Vet. Res. (1992) 53(4):517–520.
  • BLIZZARD T, FISHER MH, MROZ1K H, Siitx TL: Recent Progress in the Chemical Synthesis of Antibiotics (1990). LUKACS G, OHNO M (Eds), Springer-Verlag, New York, Chapter 3 For an in-depth chemistry review which covers the patent literature prior to 1991 see: DAVIES HG, GREEN RH: Avermectins and Milbemycins Part H. Chem. Soc. Rev. (1991) 20:271–339.
  • CYDECTINTM, THE C-23 METHOX1ME OF LL-F28249a, CARTER GT, N1ETSCHE JA, BORDERS DB: Structure Determination of LL-F28249a, I3,y, and 6, Potent Antiparasitic Macrolides from Streptomyces cyaneogriseus spp. non-cyanogenus. .1. Chem. Soc. Chem. Commun. (1987) 402–404.
  • TURNER MJ, SCHAEFFER JM: Mode of Actionof Ivermectin. In: Ivermectin and Abamectin. (1989) Campbell WC (Ed), Springer-Verlag, New York, Chapter 5.
  • ROHERER SP, MEINKE PT, HAYES EC, MROZIK H, SCHAEFFER JM: Photoaffinity-labelling of Avermectin Binding Sites from Caenorhab-ditis elegans and Drosophila melanogaster. Proc. Natl. Acad. Sci. USA (1992) 89(9):4168–4172.
  • MEINKE PT et al.: Affinity Probes for Aver-mectin Binding Proteins. J. Med. Chem. (1992) 35:3879–3884.
  • BLIZZARD TA, RUBY CL, MROZIK H, PREISER FA, FISHER MH: Brine Shrimp (Artemia Salina) as a Convenient Bioassay for Aver-mectin Analogs. J. Antibiotics (1989) 42(8): 1304–1307.
  • MROZIK H, LINN BO, ESKOLA P, Lusi A, MATZUK A, PREISER FA, OSTLIND DA, SCHAE-FFER JM, FISHER MH: Syntheses and Biologi-cal Activities of 13-Substituted Avermectin Aglycons. J. Med. Chem. (1989) 32:375–381.
  • Contains biodata for comparison to recent milbemycin analogues.
  • BLIZZARD TA, MARGIATTO GM, MROZIK H, SHOOP WL, FRANKSHUN RA, FISHER MH: Synthesis and Biological Activity of 13-epi-Avermectins: Potent Anthelmintic Agents with an Increased Margin of Safety. J. Med. Chem. (1992) 35:3873–3878.
  • BLIZZARD T, MARGIATTO G, LINN B, MROZIK H, FISHER M: Avermectin Analogs with a Spacer Between the Aglycone and the Dis-accharide. Bioorg. Med. Chem. Lett. (1991) 1(7):369–372.
  • MROZIK H et al.: Discovery of Novel Aver-mectins with Unprecedented Insecticidal Ac-tivity. Experientia (1989) 45:315–316.
  • MEINKE PT, SINCLAIR P, MROZIK H, O'CONNOR S, OSTLIND DA, SHOOP WL, ARISON BH, FISHER MH: A Synthesis of Avermectin B1-4",4"a-Oxide: Precursor of Potent An-thelmintic Agents. Bioorg. Med. Chem. Lett. (1992) 2(6):537–540.
  • SHIH TL, HOLMES MA, MROZIK H, FISHER MH: A Synthesis of an Avermectin-Ne-madectin Hybrid. Tetrahedron Lett. (1991) 32(30):3663–3666.
  • SHIH TL et al.: Cleavage of the Spiroketal Portion of Avermectin B2a. Tetrahedron Lett. (1990) 31(25):3525–3528.
  • SHIH TL et al.: A Wittig Approach to Novel C24 and C25-Substituted Avermectins. Te-trahedron Lett. (1990) 31(25):3529–3532.
  • MEINKE PT, O'CONNOR SP, MROZIK H, FISHERMH: Synthesis of Ring-Contracted, 25-Nor-6,5-Spiroketal-Modified Avermectin Deriva-tives. Tetrahedron Lett. (1992) 33(9):1203–1206.
  • PANKAVICH JA, BERGER H, SIMKINS KL: Efficacy of Moxidectin, Nemadectin, and Ivermectin Against an Ivermectin-Resistant Strain of Haemonchus Contortus in Sheep. Vet. Record (1992) 130(12):241–243.
  • POMROY WE, WHELAN N, ALEXANDER AM, WEST DW, STAFFORD K, ADLINGTON BA, CALDER SM: Multiple Resistance in Goat-Derived Ostertagia and the Efficacy of Moxidectin and Combinations of Other Anthelmintics. New Zealand Vet. J. (1992) 40(2):76–78.
  • SHOOP WL, HAINES HW, MICHAEL BF, EARY CH: Side-resistance to Avermectins and Milbemycins: Oral Activity of Ivermectin and Moxidectin Against Ivermectin-resis-tant and Susceptible Nematodes. Vet. Record (1993) In press. See also the following letters: SHOOP WL: Resistance to Avermectins and Milbemycins. Vet. Record (1992) 130(25):563 and MUDD AJ, BALDwN DR: Vet. Record (1992) 131(14375.
  • OSTLIND DA, MICKLE WG, EWANCIW DV, ANDRIULI FJ, CAMPBELL WC, HERNANDEZ S, MOCHALES S, MUNGUIRA E: Efficacy of Paraherquamide Against 6-day-old Tri-chostrongylus colubriformis in the Gerbil (Meriones unguiculatus). Res. Vet. Sci. (1990) 48:260–261.
  • SHOOP WL, EGERTON JR, EARY CH, SUHAYDA D: Anthelmintic Activity of Paraherquamide in Sheep. J. Parasitol. (1990) 76(3):349–351.
  • SHOOP WL et al.: Anthelmintic Activity of Paraherquamide in Calves. Vet. Parasitol. (1992) 43:259–263.
  • SCHAEFFER JM, BLIZZARD TA, ONDEYKA J, GOEGELMAN R, SINCLAIR PJ, MROZIK H: pH] Paraherquamide Binding to Caenorhabdi-fis Elegans, Studies on a Potent New An-thelmintic Agent. Biochem. Pharm. (1992) 43(4):679–684.
  • SHOOP WL, EARY CH, MICHAEL BF, HAINES HW, SEWARD RL: Anthelmintic Activity of Paraherquamide in Dogs. Vet. Parasitol. (1991) 40:339–341.
  • SHOOP WL et al.: Acute Toxicity of Paraherqu-amide and its Potential as an Anthelmintic. Am. J. Vet. Res. (1992) 53(11):2032–2034.
  • BLIZZARD TA, MARGIATTO G, MROZIK H, SCHAEFFER JM, FISHER MH: Chemical Mod-ifications of Paraherquamide. 4. 1-N-Sub-stituted Analogs. Tetrahedron Lett. (1991) 32(22):2441–2444 and references therein.
  • SINCLAIR PJ, SCHAEFFER JM, SHOOP WL, MROZIK H: The Preparation and Utiliza-tion of Paraherquamide-2-0-Methyl Imi-
  • SJOGREN EB, RIDER MA, NELSON PH, BINGHAM S JR, POULTON AL, EMANUEL MA, KOMUNIECKI R: Synthesis and Biological Activity of a Series of Diaryl-Substituted a-Cyano-Phydroxypropenamides, a New Class of Anthelmintic Agents. J. Med. Chem. (1991) 34:3295;3301.
  • WARSAME M, WERNSDORFER WH, PAYNE D, BJORKMANA : Susceptibility of Plasmodium falciparum in vitro to Chloroquine, Mefloquine, Quinine and Sulfadoxine/Pyrimethamine in Somalia: Relationships Between the Responses to the Different Drugs. Trans. Royal SOC. Tropical Med. Hygiene. (1991) 85:565–569.
  • BRYSON HM, GOA KL: Halofantrine: A Re-view. Drugs (1992) 43(2):236–258.
  • SCHMATDZM, SCHAEFFEJRM : Antiparasitic Agents. In: Ann, Rep. Med. Chem. (1991) Plattner (Ed), Academic Press, New York. 17: 61–170.
  • RICHARD-LENOBLE D, KOMBILA M, MARTZ M, GENDREL C, MORENO JL, ENGOHAN E, BLANC G, DUPASQUIER I, IANNASCOLI F: Ef-ficacy, Safety, and Acceptability of Halo-fantrine in the Treatment of Acute Plasmod-ium Falciparum Malaria in African Chil-
  • BRUECICNER RP, FLECKENSTEIN L: Simultane-ous Modeling of the Pharmacokinetics and
  • CHANG C, LIN-HuA T, JANTANAVIVAT C: Studies on a New Antimalarial Compound:
  • FRY M, PUDNEY M: Site of Action of the Anti-malarial Hydroxynaphthoquinone, 21trans-4-(4%Chlorophenyl)cyclohexyl]-3-hydroxy-1, 4-naphthoquinone (566C80). Biochem. Pharm. (1992) 43(7):1545–1553.
  • The Merck Index, 11th Edition, pp1455.
  • KRUNGKRAI J, KRUNGKRAI SR, PHAKANONT K: Antimalarial Activity of Orotate Analogs That Inhibit Dihydroorotase and Dihydro-orotate Dehydrogenase. Biochem. Pharm. (1992) 43(6):1295–1301.
  • NKUNYA MHH, WEENEN H, BRAY DH, MGANI QA, MWASUMBI LB: Antimalarial Activity of Tanzanian Plants and Their Active Con-stituents: The Genus Uvaria. Planta. Med. (1991) 57:341–343.
  • WHITE NJ, WALLER D, CRAWLEY J, NOSTEN F, CHAPMAN D, BREWSTER D, GREENWOOD BM: Comparison of Artemether and Chloro-quine for Severe Malaria in Gambian Chil-dren. Lancet (1992) 339:317–321.
  • LIN AJ, LI L, ANDERSEN SL, KLAYMAN DL: Antimalarial Activity of New Dihydro-artemisinin Derivatives. 5. Sugar Analogues. J. Med. Chem. (1992) 35:1639–1642.
  • The numbering scheme used in ref. 38 will be followed in subsequent discussion for the artemisinin derivatives.
  • VANELLE P, MALDONADO J, GASQUET M, DELMAS F, TIMON-DAVID P, JENTZER O, CROZET MP: Studies on Antiparasitic Agents: Effect of the Lactam Nucleus Substitution in the 2-Position on the in vitro Activity of New 5-Nitroimidazoles. J. Pharm. Pharmacol. (1991) 43:735–736.
  • WALSH C, BRADLEY M, NADEAU K: Molec-ular Studies on Trypanothione Reductase, a Target for Antiparasitic Drugs. TIBS (1991) 16:305–309.
  • RAM V.1: Synthesis of it-Deficient Pyrim-idines as Leishmanicides. Arch. Pharm. (Wein-heim) (1991) 324:837–839.
  • SETT R, BASU N, GHOSH AK, DAs PK: Po-tential of Doxorubicin as an Antileishmanial Agent. J. Parasitol. (1992) 78(2):350–354. KATIYAR SK, EDLIND TD: Enhanced Antipar-asitic Activity of Lipophilic Tetracyclines: Role of Uptake. Antimicrobial Agents Chemo-therapy (1991) 35(142198–2202. Chem. Lett. (1992) In press.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.